Moisture-resistant Electrocardiography Monitor for Wearable Cardiac Diagnostics
Summary
USPTO granted patent US12599326B2 to Bardy Diagnostics, Inc. on April 14, 2026. The patent covers a moisture-resistant wearable ECG monitor featuring a flexible extended wear electrode patch and a reusable monitor recorder that snaps into a receptacle on the patch. The monitor is positioned along the sternal midline and is designed to capture P-wave and QRS interval signals for improved cardiac diagnostics.
What changed
USPTO granted patent US12599326B2 to Bardy Diagnostics, Inc. for a moisture-resistant wearable ECG monitor. The invention comprises a flexible extended wear electrode patch and a reusable monitor recorder that removably snaps into a receptacle on the electrode patch. The monitor is positioned at the sternal midline in a narrow hourglass shape to improve sensing of P-wave and QRS interval signals during cardiac monitoring.
This patent grant establishes intellectual property protection for Bardy Diagnostics' cardiac monitoring technology. Competitors developing similar wearable ECG devices should review the patent claims to ensure their products do not infringe on the protected design. Medical device manufacturers entering the cardiac monitoring space may need to consider licensing arrangements or design alternatives.
What to do next
- Monitor for updates
Archived snapshot
Apr 14, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Moisture-resistant electrocardiography monitor
Grant US12599326B2 Kind: B2 Apr 14, 2026
Assignee
Bardy Diagnostics, Inc.
Inventors
Jon Mikalson Bishay, Jason Felix, Gust H. Bardy
Abstract
Physiological monitoring can be provided through a lightweight wearable monitor that includes two components, a flexible extended wear electrode patch and a reusable monitor recorder that removably snaps into a receptacle on the electrode patch. The wearable monitor sits centrally on the patient's chest along the sternum oriented top-to-bottom. The placement of the wearable monitor in a location at the sternal midline, with its unique narrow “hourglass”-like shape, significantly improves the ability of the wearable monitor to cutaneously sense cardiac electrical potential signals, particularly the P-wave and the QRS interval signals indicating ventricular activity in the ECG waveforms. In particular, the ECG electrodes on the electrode patch are tailored to be positioned axially along the midline of the sternum for capturing action potential propagation in an orientation that corresponds to the aVF lead used in a conventional 12-lead ECG that is used to sense positive or upright P-waves.
CPC Classifications
A61B 5/0006 A61B 5/282 A61B 5/1118 A61B 2560/0412 A61B 5/25 A61B 5/318 A61B 5/332 A61B 5/6833 A61B 5/259 A61B 5/6823
Filing Date
2025-05-19
Application No.
19212310
Claims
20
Related changes
Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.